Skip to content
Exits and Outcomes
Sign In
Subscribe
Digital health research, news, and analysis from Brian Dolan.
$200/year or
consider an Enterprise subscription
.
Prescription Digital Therapeutics
All Newsletters
179 articles
2 of 18
Breaking: Pear Therapeutics files for Chapter 11 bankruptcy
4.07.23
4
min. Read
E&O readers analyze fate of Pear, PDTs. FDA-AI
3.31.23
8
min. Read
FDA waiver ends Nov 7. Withings ScanWatch recall, revs
3.24.23
10
min. Read
Pear seeks buyer. Lobbying for a CMS benefit category.
3.17.23
6
min. Read
CMS to pay for VR-based CBT. No HCPCS for CanvasDx.
3.10.23
8
min. Read
Cigna snubs RTM. Orexo PDT reorg. Pear CCO leaves.
3.03.23
8
min. Read
Oui Therapeutics spun out a virtual clinic. physIQ revs, bankruptcy.
2.17.23
9
min. Read
Three new Medicaid Rx digital therapeutic bills. Trials
2.10.23
5
min. Read
Highmark won’t pay for every FDA-cleared prescription digital therapeutic. Clinical Trials.
1.27.23
7
min. Read
Florida Medicaid covers Pear. MedRhythms pivotal. Trials
1.20.23
6
min. Read
1 of 18